Our Services
Medical Information
Helpful Resources
Published on: 6/14/2026
A positive BRCA gene mutation result means you carry an inherited change in a DNA repair gene, raising your lifetime risk for breast, ovarian, prostate, pancreatic, and other cancers — but it does not mean you currently have cancer. Recommended next steps typically include genetic counseling, enhanced surveillance (breast MRI, mammography, and targeted blood work), and risk-reducing options such as preventive surgery, chemoprevention, or medication.
Key considerations include personalized screening schedules, surgical decisions, chemoprevention, cascade testing for relatives, lifestyle modifications, and emotional support.
Because BRCA-related risks vary widely based on your age, sex, family history, and personal health, a one-size-fits-all answer isn't useful — and waiting for your next appointment can add unnecessary anxiety. Take a free, instant, online symptom check now to clarify your concerns, identify red flags, and confidently plan your next steps.
Reviewed for medical accuracy: 06/14/2026
BRCA Gene Mutation: What a Positive Result Means and What Doctors Recommend Next
A BRCA gene mutation is a change in one of the BRCA1 or BRCA2 genes, which normally help repair damaged DNA. When these genes don't work properly, the risk of developing certain cancers—most notably breast and ovarian cancer—increases. If you've received a positive test result for a BRCA gene mutation, you're not alone. Many people face similar outcomes and find ways to manage their health proactively.
A positive BRCA gene mutation result does not mean you have cancer. It means your lifetime risk of certain cancers is higher than average. Understanding these risks helps you, your doctor, and your family make informed decisions.
Key risk estimates for women with a BRCA gene mutation:
For men with a BRCA gene mutation:
Other possible risks with BRCA mutations (both sexes):
These percentages are estimates based on current research. Individual risk can vary depending on family history, lifestyle, and other genetic factors.
Genetic Counseling
Enhanced Screening and Surveillance
Early detection can improve outcomes. Common strategies include:
Risk-Reducing Surgeries
Prophylactic (preventive) surgeries can dramatically lower risk but carry their own considerations. Discuss thoroughly with your medical team. Options include:
Chemoprevention
Certain medications may reduce breast cancer risk:
Lifestyle Modifications
While they can't eliminate genetic risk, healthy habits contribute to overall wellness:
Family Implications
Learning you carry a BRCA gene mutation can be overwhelming. It's normal to feel a mix of emotions:
Consider these resources:
If you experience any new or concerning symptoms—such as unusual lumps, persistent pain, or unexplained weight loss—seek medical evaluation promptly. You can also try Ubie's Medically approved LLM Symptom Checker Chat Bot to get personalized guidance on whether you should seek urgent care or schedule an appointment with your doctor.
Always remember:
A positive BRCA gene mutation result means you have a higher-than-average lifetime risk for certain cancers, but it also empowers you to take proactive steps:
By partnering with your healthcare team, you can create a personalized plan to monitor and reduce cancer risk. Remember, advances in genetics and cancer prevention are ongoing; staying informed and taking proactive measures offers the best path forward.
(References)
* Aghasi M, Oskouei K, Ghanei M, Shourbandi SH, Bagheri L, Malih N, Shahab S, Rahsepar M. BRCA1/2 Management: A Narrative Review. Mol Biol Rep. 2023 Apr 19. doi: 10.1007/s11033-023-08343-9. Epub ahead of print. PMID: 37077679.
* Mersch J, Goetz M, Liu R, Cox H, Chen P, Sahoo T, Amos C, Blazer K, Anguiano A, Nussbaum R, et al. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. Nat Rev Cancer. 2017 Jan 23;17(3):141-152. doi: 10.1038/nrc.2016.141. PMID: 28111367.
* Petrucelli N, Daly MB. Management of individuals with BRCA1/2 mutations: A systematic review and meta-analysis. Clin Genet. 2020 Jan;97(1):50-60. doi: 10.1111/cge.13529. Epub 2019 Dec 19. PMID: 31804709.
* Rebbeck TR. Genetic testing for hereditary breast and ovarian cancer syndromes: current landscape and future prospects. Cancer Metastasis Rev. 2021 May;40(1):31-41. doi: 10.1007/s10555-021-09944-y. Epub 2021 Mar 22. PMID: 33917878; PMCID: PMC8130848.
* Tung N, Armstrong D, Bandyopadhyay S, Boughey JC, Burke E, Callegari L, Chang J, Choi J, D'Andrea K, Dayao Z, Dean D, Garber J, Gemignani ML, Grubb C 3rd, Guenther J, Hughes KS, Jaskowiak N, Jensen J, Krop I, Liu A, Matulonis U, Mitchell H, Mukherji D, Obeid E, Puhalla SL, Ruddy KJ, Saam J, Shaughnessey A, Stearns V, Traina A, Ulahannan S, Van Poznak M, von Minckwitz G, Winer EP, Zafonte BT, Pal T. BRCA1/2 Germline Mutation Testing in Women with Breast Cancer: ASCO Guideline. J Clin Oncol. 2024 Apr 1;42(10):1179-1199. doi: 10.1200/JCO.23.02325. Epub 2024 Feb 5. PMID: 38315802.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.